Illustration: Tiffany Herring/Axios
McKesson agreed to acquire pharma services company Precision Medicine Group from Blackstone for about $2.25 billion, it announced Tuesday.
The big picture: After buying deeper into specialty physician practices, McKesson is moving upstream to help drugmakers develop and launch therapies.
